JP7343478B2 - 処置の方法 - Google Patents

処置の方法 Download PDF

Info

Publication number
JP7343478B2
JP7343478B2 JP2020505881A JP2020505881A JP7343478B2 JP 7343478 B2 JP7343478 B2 JP 7343478B2 JP 2020505881 A JP2020505881 A JP 2020505881A JP 2020505881 A JP2020505881 A JP 2020505881A JP 7343478 B2 JP7343478 B2 JP 7343478B2
Authority
JP
Japan
Prior art keywords
compound
raynaud
pharmaceutical composition
individual
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2020505881A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020530447A (ja
JP2020530447A5 (enExample
Inventor
ダブリュー． アダムス，ジョン
エム． アンダーソン，クリステン
アール． シャナハン，ウィリアム
Original Assignee
アレーナ ファーマシューティカルズ，インク．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アレーナ ファーマシューティカルズ，インク． filed Critical アレーナ ファーマシューティカルズ，インク．
Publication of JP2020530447A publication Critical patent/JP2020530447A/ja
Publication of JP2020530447A5 publication Critical patent/JP2020530447A5/ja
Application granted granted Critical
Publication of JP7343478B2 publication Critical patent/JP7343478B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
JP2020505881A 2017-08-07 2018-08-07 処置の方法 Active JP7343478B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201762541956P 2017-08-07 2017-08-07
US62/541,956 2017-08-07
US201862711369P 2018-07-27 2018-07-27
US62/711,369 2018-07-27
PCT/US2018/045683 WO2019032626A1 (en) 2017-08-07 2018-08-07 Methods of treatment

Publications (3)

Publication Number Publication Date
JP2020530447A JP2020530447A (ja) 2020-10-22
JP2020530447A5 JP2020530447A5 (enExample) 2021-09-16
JP7343478B2 true JP7343478B2 (ja) 2023-09-12

Family

ID=63364217

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020505881A Active JP7343478B2 (ja) 2017-08-07 2018-08-07 処置の方法

Country Status (5)

Country Link
US (2) US20200368190A1 (enExample)
EP (1) EP3664792A1 (enExample)
JP (1) JP7343478B2 (enExample)
CA (1) CA3072079A1 (enExample)
WO (1) WO2019032626A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2367797A1 (en) 2008-11-26 2011-09-28 Arena Pharmaceuticals, Inc. Pyrazolyl substituted carbonic acid derivatives as modulators of the prostacyclin (pgi2) receptor useful for the treatment of disorders related thereto
US8940891B2 (en) 2008-12-08 2015-01-27 Arena Pharmaceuticals, Inc. Modulators of the prostacyclin (PGI2) receptor useful for the treatment of disorders related thereto
AU2023222747A1 (en) 2022-02-15 2024-08-22 United Therapeutics Corporation Crystalline prostacyclin (ip) receptor agonist and uses thereof
WO2025193579A1 (en) 2024-03-11 2025-09-18 United Therapeutics Corporation Methods of making ip-receptor agonists

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011515396A (ja) 2008-03-18 2011-05-19 アリーナ ファーマシューティカルズ， インコーポレイテッド プロスタサイクリン（ｐｇｉ２）受容体に関連する障害の処置に有用なｐｇｉ２受容体の調節因子

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10188648B2 (en) * 2015-09-03 2019-01-29 Teva Pharmaceuticals International Gmbh Solid state forms of selexipag

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011515396A (ja) 2008-03-18 2011-05-19 アリーナ ファーマシューティカルズ， インコーポレイテッド プロスタサイクリン（ｐｇｉ２）受容体に関連する障害の処置に有用なｐｇｉ２受容体の調節因子

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
Annals of the Rheumatic Diseases，1995年，Vol.54，p.197-200
Expert Review of Clinical Pharmacology，2017年05月，Vol.10, No.7，p.753-762
Journal of Medicinal Chemistry，2017年01月，Vol.60，p.913-927
Le Revue de Medecine Interne，1985年，Vol.6, No.5，p.581-589
臨床と研究，1990年，Vol.67, No.1，p.234-242

Also Published As

Publication number Publication date
US20200368190A1 (en) 2020-11-26
CA3072079A1 (en) 2019-02-14
WO2019032626A1 (en) 2019-02-14
JP2020530447A (ja) 2020-10-22
EP3664792A1 (en) 2020-06-17
US20240122886A1 (en) 2024-04-18

Similar Documents

Publication Publication Date Title
JP7343478B2 (ja) 処置の方法
JP5442178B2 (ja) ロキソプロフェン含有経口用組成物
RU2672248C1 (ru) Применение производного бензимидазола для лечения ночного кислотного прорыва
KR101298348B1 (ko) 조루증 치료를 위한 경구용 의약 조성물
JP2022507533A (ja) 肺動脈性高血圧症および他疾患に関連する肺動脈性肺高血圧症の治療法
JP6192751B2 (ja) ロキソプロフェン含有経口用組成物５
CN113784717A (zh) 一种治疗肺动脉高压和相关性肺动脉高压的方法以及每日给药
JPWO2015129750A1 (ja) 慢性腎臓病の進行抑制又は改善剤
JP2017533956A (ja) 筋肉痛を含む病態の治療のための組合せ
JP7668386B2 (ja) １－（３－シアノ－１－イソプロピル－インドール－５－イル）ピラゾール－４－カルボン酸を含む薬学的組成物
JP5296968B2 (ja) イブプロフェン含有経口用医薬組成物
KR101598283B1 (ko) 안전성 및 효능이 증가된 월경통 완화 또는 치료용 복합제 조성물
Igloe Effects of methyldopa in hypertension
US20240252503A1 (en) Methods of treatment
JP7768720B2 (ja) ポルフィリン症の予防又は治療剤
JP4993998B2 (ja) イブプロフェンを含有する医薬組成物
CN116251098A (zh) 去氢骆驼蓬碱在制备治疗和/或预防肺动脉高压的药物中的用途
HU196125B (en) Process for producing pharmaceutical comprising 3-(aminopropoxy)-indole derivatives combined with diuretic
EA050266B1 (ru) Фармацевтическая композиция, включающая 1-(3-циано-1-изопропилиндол-5-ил)пиразол-4-карбоновую кислоту
TW202214238A (zh) 在單層片劑中包括氨氯地平、氯沙坦和氯噻酮的預防或治療心血管系統疾病的藥學上組合製劑
HK40058221A (en) A method for treating pulmonary arterial hypertension and associated pulmonary arterial hypertension
JPS5839623A (ja) トラゾドンを必須成分とする抗潰瘍剤
TW201200131A (en) Use of dronedarone for the preparation of a medicament for the prevention of cardiovacular hospitalizations or death or cardiovascular events in patients with premanent atrial fibrillation

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200521

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210806

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210806

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220518

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220525

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220810

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20221118

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20221214

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20230313

RD12 Notification of acceptance of power of sub attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7432

Effective date: 20230323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20230323

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230613

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20230807

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20230831

R150 Certificate of patent or registration of utility model

Ref document number: 7343478

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150